Purchase Order 75N98026P01203

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for an EVOS M5000 imaging system, valued at $21,875.59, on August 5, 2026. The order carries no set-aside designation and is priced as firm fixed price. Place of performance is Carlsbad, California. Ultimate completion is scheduled for August 4, 2027.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for an EVOS imaging system valued at $20,811.81 on September 6, 2018, with completion by October 6, 2018. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $20,776.50 on September 5, 2019, with completion by October 5, 2019. Place of performance is Carlsbad, California. The order represents a firm fixed-price, commercial purchase of laboratory instrumentation, reagents, or consumables—Life Technologies' core federal offering in genetic analysis and molecular biology. No set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $22,130 in lab equipment on June 9, 2021, with completion by July 9, 2021. The award carries no small business set-aside. Performance is in Carlsbad, California. The order is firm fixed price and was issued to de-obligate expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 close of the period of availability.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $10,146.00 on July 25, 2017, for laboratory supplies with ultimate completion on August 23, 2017. Place of performance is Carlsbad, California. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biological kits valued at $14,923.40 on August 24, 2020, with an ultimate completion date of September 23, 2020. Place of performance is Carlsbad, California. The order carries firm fixed pricing with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab supplies on August 29, 2017, with a ceiling value of $14,198.40 and completion date of September 28, 2017. Performance occurs in Carlsbad, California. The order is firm fixed price with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $5,611.84 on July 11, 2017, with ultimate completion on August 16, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is for laboratory instrumentation, reagents, consumables, or maintenance services typical of Life Technologies' federal portfolio in life-sciences research and diagnostic infrastructure. Pricing is firm fixed price.</p>